GSK PLC AdrhedgedGSKHETF
13F holders, Q4 2025 (December 31)1holders
0new positions
0sold out
$68.20avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding GSK PLC Adrhedged (GSKH) in their 13F filings, unchanged from Q3 2025. 0 opened new positions and 0 sold out. The largest holder was UBS Group AG ($4K).
- Company
- GSK PLC Adrhedged
- Filed as
- PRECIDIAN ETFS TR (Q4 2025)
- CUSIP
- 74016W874
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 35 shares sold, net −35 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| UBS Group AG | 0.00% | Reduce -35.0% | 65 | $4K |
"% of holder's portfolio" is GSKH's weight in each manager's 13F, not the share of GSK PLC Adrhedged the manager owns.